Robbins-Welty, G. A., Tuck, A. N., Marchant, D., Gleason, A., Key, R. G., Lubrano di Ciccone, B. B., … McFarland, D. (2023). Bleeding Risk With SSRIs PART 1: Cardiovascular and Cerebrovascular Considerations. Psychiatric Times, 40(9), 35–39.

Robbins-Welty, G. A., A. N. Tuck, D. Marchant, A. Gleason, R. G. Key, B. B. Lubrano di Ciccone, D. A. Chopra, et al. “Bleeding Risk With SSRIs PART 1: Cardiovascular and Cerebrovascular Considerations.” Psychiatric Times 40, no. 9 (September 1, 2023): 35–39.

Robbins-Welty GA, Tuck AN, Marchant D, Gleason A, Key RG, Lubrano di Ciccone BB, et al. Bleeding Risk With SSRIs PART 1: Cardiovascular and Cerebrovascular Considerations. Psychiatric Times. 2023 Sep 1;40(9):35–9.

Robbins-Welty, G. A., et al. “Bleeding Risk With SSRIs PART 1: Cardiovascular and Cerebrovascular Considerations.” Psychiatric Times, vol. 40, no. 9, Sept. 2023, pp. 35–39.

Robbins-Welty GA, Tuck AN, Marchant D, Gleason A, Key RG, Lubrano di Ciccone BB, Chopra DA, Mojtahedzadeh M, Fonseca F, Amonoo HL, DeSimone A, McFarland D. Bleeding Risk With SSRIs PART 1: Cardiovascular and Cerebrovascular Considerations. Psychiatric Times. 2023 Sep 1;40(9):35–39.